CompletedPhase 2NCT02486289
Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication
Studying Mercury poisoning
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- EmeraMed
- Principal Investigator
- Augusto Focil Baquerizo, MDFOMAT Medical Research
- Intervention
- Emeramide(drug)
- Enrollment
- 36 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2015 – 2016
Study locations (1)
- Hospital Doctor Humberto Molina, Zaruma, Ecuador
Collaborators
NBMI Science AB
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02486289 on ClinicalTrials.gov